Decoy Therapeutics (DCOY) Long-Term Investments (2015)
Decoy Therapeutics (DCOY) posted quarterly Long-Term Investments of $2.3 million for Q4 2015.
Decoy Therapeutics (DCOY) Long-Term Investments (2015) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Long-Term Investments for 1 consecutive years, with $2.3 million the latest figure, recorded in Q4 2015.
- In Q4 2015, Long-Term Investments changed N/A year-over-year to $2.3 million; the TTM figure through Dec 2015 stood at $2.3 million (changed N/A YoY), while the FY2015 annual figure was $2.3 million, changed N/A from the prior year.
- Long-Term Investments steadied at $2.3 million in Q4 2015 per DCOY's latest filing.
- Across five years, Long-Term Investments topped out at $2.3 million in Q4 2015 and bottomed at $2.3 million in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 5.79 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 9.83 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 1.77 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 22.17 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 372.10 Mn |
| 10 | Decoy Therapeutics | 1.75 Mn | 1.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 2.31 Mn |